What is the prevalence of Progressive Supranuclear Palsy?
How many people does Progressive Supranuclear Palsy affect? Does it have the same prevalence in men and women? And in the different countries?
Progressive Supranuclear Palsy (PSP) is a rare neurodegenerative disorder characterized by the deterioration of certain brain cells. It affects an estimated 3 to 6 in every 100,000 people worldwide, making it relatively uncommon. PSP typically occurs in individuals aged 60 and above, with symptoms including balance and coordination problems, eye movement difficulties, and cognitive impairments. While PSP is not as prevalent as other neurodegenerative diseases like Alzheimer's or Parkinson's, it still poses significant challenges for those affected and their families.
Progressive Supranuclear Palsy (PSP) is a rare neurodegenerative disorder that affects the brain. It is estimated that PSP affects approximately 6 in every 100,000 individuals worldwide, making it a relatively uncommon condition.
PSP is more prevalent in individuals over the age of 60, with the average age of onset being around 63 years. It is slightly more common in men than in women. The exact cause of PSP is still unknown, and there are no known risk factors that can predict its development.
The symptoms of PSP can vary but often include difficulties with balance and coordination, changes in behavior and mood, problems with eye movements, and cognitive decline. These symptoms can significantly impact an individual's quality of life and daily functioning.
While PSP is not as prevalent as other neurodegenerative disorders like Parkinson's disease, it is important to raise awareness about this condition to ensure early diagnosis and appropriate management. Further research is needed to better understand the causes and potential treatments for PSP.
Posted Aug 12, 2017 by Diana Sanders 2000
Posted Nov 8, 2017 by Maria Veronica Ortiz Solís 2000
